Critical evaluation of 99mTc glucoheptonate as a brain imaging agent.
99mTc glucoheptonate was used as a brain imaging agent in a consecutive series of 859 patients. Sensitivity was 94% in patients with proved CNS tumors. Static imaging of patients with infarction showed a sensitivity of 62%. When the perfusion study was included, this valve increased to 90%. Overall sensitivity was 83%, specificity 99%, and accuracy 95% without inclusion of perfusion results. When these results were included, overall sensitivity was 93%, specificity 99%, and accuracy 98%.
D001921:Brain / Q000000981:diagnostic imaging*; D001927:Brain Diseases / Q000000981:diagnostic imaging*; D001932:Brain Neoplasms / Q000000981:diagnostic imaging*; D003951:Diagnostic Errors; D004341:Drug Evaluation; D005260:Female; D006539:Heptoses; D006801:Humans; D008875:Middle Aged; D011877:Radionuclide Imaging; D013400:Sugar Acids; D013667:Technetium
D006539:Heptoses; D013400:Sugar Acids; D013667:Technetium